Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,344 public trials 2,835 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Active, Not Recruiting

A Phase II Study of the BRAF Inhibitor, Vemurafenib, Plus Obinutuzumab in Patients With Previously Untreated Classical Hairy Cell Leukemia

NCT03410875

Conditions
Hairy Cell Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
Locations
  • Yale University New Haven, Connecticut, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Memorial Sloan Kettering at Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
View Trial Details
Active, Not Recruiting

SEDVasc (RaDiCo Cohort) (RaDiCo-SEDVasc)

NCT05976841

Conditions
Aneurysm, Aortic Dissection, Cardiovascular Diseases, +18 more
Locations
  • Centre Hospitalier Universitaire Angers Angers, France
  • Hôpital Saint-André Bordeaux, France
  • Hôpital de la Cavale Blanche Brest, France
  • Hôpital Côte de Nacre Caen, France
View all 17 locations
View Trial Details
Active, Not Recruiting

Improvement of Immunologic and Molecular Techniques for the Diagnosis and Follow-up of Patients With Thrombotic Thrombocytopenic Purpura

NCT05046717

Conditions
Acquired Thrombotic Thrombocytopenic Purpura, Blood Coagulation Disorders, Blood Platelet Disorders, +14 more
Locations
  • Centro Hospitalar e Universitario de Coimbra Coimbra, Coimbra District, Portugal
  • Complejo Hospitalario Universitario A Coruña A Coruña, Spain
  • Hospital Clinic de Barcelona Barcelona, Spain
  • Hospital Clínico San Carlos Madrid, Spain
View Trial Details
Active, Not Recruiting

A Study to Compare the Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care Versus Best Supportive Care as Maintenance Therapy in Japanese Participants With Acute Myeloid Leukemia (AML) in Complete Remission

NCT05197426

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Local Institution - 0011 Huntsville, Alabama, United States
  • Local Institution - 0017 Nagoya, Aichi-ken, Japan
  • Local Institution - 0023 Nagoya, Aichi-ken, Japan
  • Local Institution - 0009 Toyoake, Aichi-ken, Japan
View all 31 locations
View Trial Details
Active, Not Recruiting

Study of Anitocabtagene-autoleucel in Participants With Relapsed Refractory Multiple Myeloma

NCT04155749

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations
  • Advanced Cellular Therapeutics Facility, DCAM 0800A Chicago, Illinois, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Froedtert Hospital/Medical College of Wisconsin Milwaukee, Wisconsin, United States
View Trial Details
Active, Not Recruiting

SARS-CoV-2 Vaccine (GEO-CM04S1) Versus mRNA SARS-COV-2 Vaccine in Patients With Blood Cancer

NCT04977024

Conditions
Blood Protein Disorders, COVID-19, COVID-19 Infection, +30 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • U Mass Chan Medical School Worcester, Massachusetts, United States
  • SUNY-Stony Brook Stony Brook, New York, United States
View Trial Details
Active, Not Recruiting

Study of Anitocabtagene-autoleucel in Relapsed or Refractory Multiple Myeloma (iMMagine-1)

NCT05396885

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • HonorHealth Cancer Transplant Institute Scottsdale, Arizona, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View all 18 locations
View Trial Details
Active, Not Recruiting

Stopping Maintenance Therapy in People With Multiple Myeloma in MRD-Negative Remission

NCT04221178

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center @ Suffolk Commack, New York, United States
View Trial Details

Related conditions